Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC of the Lung That Previously Received Platinum-based Chemotherapy

Clinical trial NCT06736418 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06736418
Sponsor: Abdera Therapeutics Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Small-Cell Lung Cancer (SCLC)Large Cell Neuroendocrine Carcinoma of the Lung

Start date: 2025-03-10
Primary completion: 2026-08-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.